| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 06/26/2002 | EP1216037A2 Methods and compositions for treating platelet-related disorders using mpl pathway inhibitory agents |
| 06/26/2002 | EP0820441B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS |
| 06/26/2002 | EP0692963B1 Use of terbinafine for the therapeutic treatment of pneumocystosis |
| 06/26/2002 | CN1355881A Growth differentiation factor inhibitors and uses therefor |
| 06/26/2002 | CN1355846A Method for down-regulating IL5 activity |
| 06/26/2002 | CN1355802A Substituted porphyrins |
| 06/26/2002 | CN1355799A 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
| 06/26/2002 | CN1355710A Combination vaccine against streptocouus pneumoniae and repiratory syncytial virus (RSV) |
| 06/26/2002 | CN1355701A Urea substituted imidazoquinolines |
| 06/26/2002 | CN1355698A Compound for medicine for treating function of bronchial contraction |
| 06/26/2002 | CN1355693A Controlled release and taste masking oral pharmaceutical compositions |
| 06/26/2002 | CN1355290A 'Zheng' wine |
| 06/26/2002 | CN1355044A Medicine for treating nasosinusitis |
| 06/26/2002 | CN1355025A Capsule 'Bimingan'-for treating allergic rhinitis |
| 06/26/2002 | CN1355021A Percutaneous medicine of strychnine (toxiferine or securinine) and salt thereof |
| 06/26/2002 | CN1355014A Process for preparing medicine to treat rhinitis, nasosinusitis and frontal sinusitis by spraying it into nose or exterior application and its application |
| 06/26/2002 | CN1086585C Medicine for pulmonary diseases and its preparation method |
| 06/25/2002 | US6410791 Salbutamol; respiratory system disorders |
| 06/25/2002 | US6410588 Use of cannabinoids as anti-inflammatory agents |
| 06/25/2002 | US6410583 Prostaglandin antagonist |
| 06/25/2002 | US6410553 Benzosulfones and related compositions and methods |
| 06/25/2002 | US6410552 Benzoether and related compositions and methods |
| 06/25/2002 | US6410551 Bronchodilator |
| 06/25/2002 | US6410547 Phenylpyridine derivatives useful as phosphodiesterase inhibitors |
| 06/25/2002 | US6410540 Inhibitors of p38-αkinase |
| 06/25/2002 | CA2240964C Piperidone tachykinin antagonists |
| 06/25/2002 | CA2234847C Formulation for respiratory tract administration |
| 06/25/2002 | CA2099586C Drug material suitable for micronisation |
| 06/25/2002 | CA2071981C The use of gaba-b selective agonists as anti-tussive agents |
| 06/25/2002 | CA2045546C Treatment of pulmonary dysfunction and ventilator dependency with growth hormone |
| 06/20/2002 | WO2002048397A2 Regulation of human adenylate cyclase, type vii |
| 06/20/2002 | WO2002048358A2 Regulation of human chemokine-like receptor |
| 06/20/2002 | WO2002048348A1 Novel gene existing in human leukocyte antigen domain |
| 06/20/2002 | WO2002048337A2 Secreted human proteins |
| 06/20/2002 | WO2002048148A2 Pyrazolopyridine derivatives |
| 06/20/2002 | WO2002048145A1 Aminotriazolopyridiine derivatives as adenosine receptor ligands |
| 06/20/2002 | WO2002048124A2 Piperazine derivatives |
| 06/20/2002 | WO2002048107A1 Antitumoral carbazoles |
| 06/20/2002 | WO2002047762A1 Serine protease inhibitors |
| 06/20/2002 | WO2002047711A2 Modulators of activity of g-protein-coupled receptor kinases |
| 06/20/2002 | WO2002047708A2 Selective cox-2 inhibition from edible plant extracts |
| 06/20/2002 | WO2002047706A2 Selective cox-2 inhibition from plant extracts |
| 06/20/2002 | WO2002047704A1 Herbal pharmaceutical compositions for treating immunological disorders |
| 06/20/2002 | WO2002047700A1 Composite & making method of medicines for cold treatment |
| 06/20/2002 | WO2002047687A1 Urotensin-ii receptor antagonists |
| 06/20/2002 | WO2002047674A2 Use of intracellular calcium chelators (e.g bapta-am) to increase surfactant secretion in the lungs |
| 06/20/2002 | WO2002047672A2 Treatment of cystic fibrosis with alkalinizing agents |
| 06/20/2002 | WO2002047668A2 Novel medicament compositions based on anticholinesterase drugs and on ciclesonides |
| 06/20/2002 | WO2002047667A2 Novel medicament compositions based on anticholinesterase drugs and on a steroid |
| 06/20/2002 | WO2002047493A2 Health promoting compositions |
| 06/20/2002 | WO2002047456A2 Urotensin-ii receptor antagonists |
| 06/20/2002 | WO2002030888A3 Tricyclic compounds and uses thereof |
| 06/20/2002 | WO2002016436A3 ANTIBODIES TO HUMAN IL-1$g(b) |
| 06/20/2002 | WO2002012214A3 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 06/20/2002 | WO2001085942A3 Cytoskeleton-associated proteins |
| 06/20/2002 | WO2001085096A3 Mast cell regulation |
| 06/20/2002 | WO2001079487A3 Polydesoxyribonucleotides for inhibiting the expression of the icam-1-gene |
| 06/20/2002 | WO2001077164A3 Diagnosis of diseases associated with apoptosis by means of assessing the methylation status of genes associated with apoptosis |
| 06/20/2002 | WO2001072830A3 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction |
| 06/20/2002 | WO2001044445A8 Human lyases and associated proteins |
| 06/20/2002 | WO2001036448A8 Preparation and composition of peptides useful for treatment of autoimmune and transplant related graft versus host conditions |
| 06/20/2002 | WO2001003688A3 Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds |
| 06/20/2002 | WO2000061750A9 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS |
| 06/20/2002 | WO2000061596A8 50 human secreted proteins |
| 06/20/2002 | US20020077482 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 06/20/2002 | US20020077356 Nonsteroidal antiinflammatory agents |
| 06/20/2002 | US20020077339 Chemokine receptor binding heterocyclic compounds |
| 06/20/2002 | US20020077337 Chemical compounds |
| 06/20/2002 | US20020077333 For therapy inflammation, inflammatory diseases, immunologic diseases and other diseases mediated by tumor necrosis factor-alpha (TNF-alpha) and/or interleukin 6 or 10 and/or enzyme cyclooxygenase-2 (COX-2) |
| 06/20/2002 | US20020077329 EP4 receptor inhibitors to treat rheumatoid arthritis |
| 06/20/2002 | US20020077304 Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds |
| 06/20/2002 | US20020076800 Protein |
| 06/20/2002 | US20020076766 Novel glucosaminidase |
| 06/20/2002 | US20020076705 Nucleotide sequences which code preferential polypeptide; for use in the detection, treatment, and prevention of alzheimer's, parkinson's, huntington's, Tourette Syndrome, meningitis, encephalitis, congenital disorders and brain |
| 06/20/2002 | US20020076421 Oral liquid mucoadhesive compositions |
| 06/20/2002 | US20020076382 As well as drug delivery devices and dosage forms |
| 06/20/2002 | DE10062712A1 Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden New pharmaceutical compositions based on anticholinergics and corticosteroids |
| 06/20/2002 | DE10060809A1 Substituierte Anthranilsäuren, ihre Verwendung als Medikament oder Diagnostikum, sowie sie enthaltendes Medikament, sowie ein pharmazeutisches Kombinationspräparat mit einem Natrium/Wasserstoff-Austausch (NHE)-Blocker Substituted anthranilic acids, their use as a medicament or diagnostic, and she containing drug, as well as a pharmaceutical combination preparation with a sodium / hydrogen exchange (NHE) blockers |
| 06/20/2002 | DE10060292A1 Verwendung substituierter Benzimidazole zur Herstellung eines Medikaments zur Behandlung von Krankheiten, welche durch Inhibierung des Na+/H+-Austauschers beeinflusst werden können und sie enthaltendes Medikament Use of substituted benzimidazoles for the manufacture of a medicament for the treatment of diseases which can be influenced by inhibiting the Na + / H + exchanger and containing medicament |
| 06/20/2002 | CA2431852A1 Herbal pharmaceutical compositions for treating immunological disorders |
| 06/20/2002 | CA2431107A1 Antitumoral carbazoles |
| 06/20/2002 | CA2428216A1 Secreted proteins |
| 06/19/2002 | EP1215587A2 Adenosine monophosphate deaminase crystal structure |
| 06/19/2002 | EP1215214A1 Novel polypeptide |
| 06/19/2002 | EP1214933A1 Method for modulating the metabolism of nitrogen oxides, compositions therefor (and variants) and method for acting on a patient's organism necessitating the metabolism of nitrogen oxides to be corrected |
| 06/19/2002 | EP1214422A1 Phosphatases which activate map kinase pathways |
| 06/19/2002 | EP1214396A1 Recombinant microorganisms expressing an oligosaccharide receptor mimic |
| 06/19/2002 | EP1214322A2 Amino-triazolopyridine derivatives |
| 06/19/2002 | EP1214318A1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives |
| 06/19/2002 | EP1214305A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of inflammation |
| 06/19/2002 | EP1214304A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes |
| 06/19/2002 | EP1214292A1 Tyrosine derivatives |
| 06/19/2002 | EP1214291A1 Biphenyl derivatives used as nhe-3 inhibitors |
| 06/19/2002 | EP1214129A1 Process for producing fine medicinal substances |
| 06/19/2002 | EP1214090A2 Novel uses of mammalian ccr6 receptors and related reagents |
| 06/19/2002 | EP1214089A1 Therapeutic uses of m3 polypeptide |
| 06/19/2002 | EP1214071A2 Treating allergic and inflammatory conditions using desloratadine |
| 06/19/2002 | EP1214056A1 Topical suspension formulations containing ciprofloxacin and dexamethasone |
| 06/19/2002 | CN1354678A Polyethyleneimine: DNA formulations for aerosol delivery |
| 06/19/2002 | CN1354657A EGF-R antagonists for treating hypersecretion of mucus in lungs |